Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 31 Melanoma 20 Neoplasms 13 Breast Neoplasms 11 Stomach Neoplasms 9 Pancreatic Neoplasms 9 Neoplasm Metastasis 9 Lung Neoplasms 9 Head and Neck Neoplasms 9 Triple Negative Breast Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Ovarian Neoplasms 8 Colorectal Neoplasms 7 Carcinoma, Renal Cell 7 Carcinoma, Hepatocellular 6 Prostatic Neoplasms 4 Hodgkin Disease 4 Glioblastoma 4 Carcinoma, Transitional Cell 4 Carcinoma 4 Uterine Cervical Neoplasms 3 Liver Neoplasms 3 Kidney Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Adenocarcinoma 3 Small Cell Lung Carcinoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms, Squamous Cell 2 Mesothelioma 2

Interventions

Methotrexate 4 Vacuum Curettage 3 Drug Therapy 2 Dactinomycin 2 pembrolizumab 1 camrelizumab 1 Vincristine 1 Surgical Procedures, Operative 1 Paclitaxel 1 Leucovorin 1 Letrozole 1 Injections 1 Etoposide 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Gestational Trophoblastic Disease × pembrolizumab × Clear all

NCT04303884 2020-03-11

CR-GTP

CHA University

Phase 2 Unknown

Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡